On the lab research market the Canadian company GenomeMe offers a range of products for immune chemo-histological cancer diagnostics.
The GeneAb antibody reagents ensure the highest veracity in detecting and differentiating cancer-specific markers of carcinomas, lymphomas, melanomas and various types of leucosis as well as liver, kidney, breast, lung, ovary, cervical, bladder, intestine, stomach, soft tissue, pancreas, brain, prostate, and thyroid gland tumors, neoplasms of neuroendocrine origin, and bone diseases.